Nephrology & Urology Clinical Trials

Statistical methods in nephrology & urology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All nephrology & urology trials

321 results

• Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 812NCT00207636
• Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer: primary endpoint results, effect estimate with confidence…Phase NAResults postedn = 46NCT03366792
• Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 12NCT00636077
• Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery: Complete Statistical AnalysisIndependent statistical analysis of Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in…Phase 3Results postedn = 19NCT04588246
• Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2): Complete Statistical AnalysisIndependent statistical analysis of Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 1NCT01534351
• Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE): Complete Statistical AnalysisIndependent statistical analysis of Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 132NCT04519294
• Comparison of Outcomes of Complex Abdominal Aortic Aneurysm Treatment: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Outcomes of Complex Abdominal Aortic Aneurysm Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04773223).Phase NAResults postedn = 925NCT04773223
• Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: primary endpoint results, effect…Phase 1/2Results postedn = 18NCT03437577
• Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids: Complete Statistical AnalysisIndependent statistical analysis of Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids: primary endpoint…Phase 3Results postedn = 122NCT00658320
• CONFIDENCE-HFIndependent statistical analysis of COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 27NCT03917459
• Conservative Treatment of Postprostatectomy Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Conservative Treatment of Postprostatectomy Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00212264).Phase NAResults postedn = 208NCT00212264
• Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).Phase 2Results postedn = 89NCT03762473
• Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 24NCT01936519
• CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: Complete Statistical AnalysisIndependent statistical analysis of CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 222NCT03998163
• Cranberry Effect on Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of Cranberry Effect on Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02996981).Phase NAResults postedn = 167NCT02996981
• Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 8NCT00514215
• CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 43NCT03628716
• CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry: Complete Statistical AnalysisIndependent statistical analysis of CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 307NCT00643617
• Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: Complete Statistical AnalysisIndependent statistical analysis of Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678313).Phase 2Results postedn = 140NCT01678313
• Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04302545).Phase NAResults postedn = 564NCT04302545
• D Mannose in Recurrent Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of D Mannose in Recurrent Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01808755).Phase 3Results postedn = 60NCT01808755
• DBSIndependent statistical analysis of DBS for Home Monitoring in Children With Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931397).Phase NAResults postedn = 30NCT01931397
• DEFEAT-AKIIndependent statistical analysis of Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04633889).Phase 2Results postedn = 320NCT04633889
• Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases: Complete Statistical AnalysisIndependent statistical analysis of Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases: primary endpoint results, effect estimate…Phase 2Results postedn = 1NCT02758132
• Desensitization in Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Desensitization in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00908583).Phase 4Results postedn = 44NCT00908583
• Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: Complete Statistical AnalysisIndependent statistical analysis of Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986947).Phase 2Results postedn = 20NCT00986947
• DHT-3Independent statistical analysis of Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00490022).Phase 1/2Results postedn = 31NCT00490022
• Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 34NCT02225860
• Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 14NCT02598895
• Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382706).Phase 2Results postedn = 15NCT01382706
• Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 18NCT03442556
• Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 18NCT01468532
• DolphinIndependent statistical analysis of A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB): primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 26NCT04641975
• Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976741).Phase 1Results postedn = 168NCT01976741
• Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 127NCT02030067
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01210560).Phase 2Results postedn = 25NCT01210560
• Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 47NCT04351750
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 153NCT00667576
• Double-J PLUS Postmarket Registry Study: Complete Statistical AnalysisIndependent statistical analysis of Double-J PLUS Postmarket Registry Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04197583).Phase NAResults postedn = 379NCT04197583
• DRIPSIndependent statistical analysis of Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919436).Phase 4Results postedn = 610NCT02919436
• DRIVEIndependent statistical analysis of Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 58NCT00465894
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 253NCT00527605
• DWETRIndependent statistical analysis of A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 12NCT01367080
• DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: Complete Statistical AnalysisIndependent statistical analysis of DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715452).Phase NAResults postedn = 114NCT03715452
• e۰Sense® Catheter Clinical Investigation: Complete Statistical AnalysisIndependent statistical analysis of e۰Sense® Catheter Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04438499).Phase NAResults postedn = 61NCT04438499
• EASYIndependent statistical analysis of Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263028).Phase NAResults postedn = 6NCT01263028
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009): Complete Statistical AnalysisIndependent statistical analysis of Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009): primary endpoint results, effect estimate with confidence…Phase 1Results postedn = 36NCT01948986
• Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 50NCT00859027
• Effect of Weight Loss on Prostate Cancer Pathology: Complete Statistical AnalysisIndependent statistical analysis of Effect of Weight Loss on Prostate Cancer Pathology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00475982).Phase NAResults postedn = 44NCT00475982
• Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 63NCT01589263

← All therapeutic areas